Prescribing patterns and drug utilization patterns of sglt2 inhibitors among diabetic outpatients in a regional teaching hospital in southern taiwan

• In: Poster presentation
• At: Seoul (South Korea) (2017)
• Type: Poster
• Poster code: POS-HPS-026
• By: CHIOU, Be-Ling (Kaohsiung Medical University, Pharmacy, Kaohsiung City, China Taiwan)
• Co-author(s): Be-Ling Chiou: Pharmacy, E-DA hospital, Kaohsiung City, Taiwan, Province of China
  Ming-Hsun Tsai: Pharmacy, E-DA hospital, Kaohsiung City, Taiwan, Province of China
  Yung-Jun Hung: Pharmacy, E-DA hospital, Kaohsiung City, Taiwan, Province of China
  Yi-Ping Hsiang: Pharmacy, E-DA hospital, Kaohsiung City, Taiwan, Province of China
  
• Abstract:

  Background

  Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are the latest class of oral anti-diabetic agents (OADs).According to the 2017 standards of America diabetes association,each new class of noninsulin agents are suggested to combine with metformin as a dual or triple therapy, including SGLT2i.

  Purpose

  We attempted to analyze the

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login